Asia-pacific Bone Densitometer Market 2022-2028
MARKET OUTLOOK
A report by Triton Market Research shows that the market for bone densitometer in the Asia-Pacific would fast progress with a CAGR of 5.22% in the forecast duration from 2022 to 2028. China, India, Japan, Australia & New Zealand, ASEAN countries, South Korea, and Rest of Asia-Pacific together form the market in this region. Indonesia and Thailand are two eminent countries in the region.
Significant changes have been made in Indonesia’s healthcare system, which is gradually gaining prominence. Further, the government here is working towards developing healthcare systems by investing in the development of healthcare services. Also, the nation is the third largest populated country in the Asia-Pacific, with a large geriatric population. Thus, the cases of osteoporosis and other bone health issues are on the rise. This, in turn, is influencing the growth of the bone densitometer market in the country.
Vietnam is a developing nation with a population of 84 million people. After several years of wars and poverty, it is now inching towards a steady market economy with rapid urbanization taking place across the entire nation. Osteoporosis is now recognized as a major public health concern. However, currently, there is a lack of documentation on the prevalence of the condition. Thus, the adoption of bone densitometers provides a new opportunity for hospitals and researchers in Vietnam for use in the field of osteoporosis.
COMPETITIVE OUTLOOK
The prominent names in the bone densitometer market are Osteometer MediTech Inc, Trivitron Healthcare, Swissray Global Healthcare Holding Ltd, BeamMed Ltd, Hologic Inc, Scanflex Healthcare AB, Medonica Co Ltd, and OSI Systems Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook